FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry, particularly to an agent possessing lymphokinetic activity. The agent possessing lymphokinetic activity contains dihydroquercetin and arabinogalactan in ratio (weight parts) 1:5.
EFFECT: agent described above possesses the synergic lymphokinetic activity.
1 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
MEDICATION POSSESSING LYMPHO KINETIC ACTIVITY | 2009 |
|
RU2423138C1 |
MEANS FOR TREATING CHRONIC VENOUS INSUFFICIENCY | 2010 |
|
RU2438686C1 |
COMPOSITION WITH HIGHER PHARMACOLOGICAL ACTIVITY OF DIHYDROQUERCETIN AND HERBAL POLYSACCHARIDES (VERSIONS) | 2010 |
|
RU2421215C1 |
METHOD FOR APPLICATION OF NATURAL STIMULATING PHYTOCOMPOSITION IN BEEKEEPING | 2021 |
|
RU2785596C1 |
MEANS OF CHRONIC VENOUS INSUFFICIENCY TREATMENT | 2022 |
|
RU2797950C1 |
METHOD OF PREVENTION AND TREATMENT OF CHRONIC VENOUS INSUFFICIENCY USING VENOLAYT BIOLOGICALLY ACTIVE ADDITIVE | 2023 |
|
RU2812617C1 |
MEDIUM WITH ANTI-TUMOUR EFFECT AND METHOD OF ITS OBTAINMENT | 2007 |
|
RU2349317C1 |
MEDICATION FOR ARTERIAL HYPERTENSION AND CARDIAC DYSRHYTHMIA TREATMENT | 2008 |
|
RU2391980C1 |
EYE MEDICINAL FILM | 2009 |
|
RU2404779C1 |
CAPILLARY PROTECTOR | 2009 |
|
RU2414230C1 |
Authors
Dates
2015-08-20—Published
2014-05-29—Filed